# Cidara Therapeutics, Inc. (CDTX)

Merck is acquiring Cidara Therapeutics for $9.2 billion, driving a significant stock surge. The company also received a BARDA award and FDA Breakthrough Therapy Designation for its influenza treatment.

### About Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. is a biotechnology company focused on developing novel therapeutics, particularly for influenza.  
Cidara Therapeutics, Inc. uses the ticker $CDTX for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Cidara Therapeutics, Inc. (CDTX) market dominance near a 52-week low at [-------].
- Cidara Therapeutics, Inc. (CDTX) social dominance is up 150% from the previous week.
- Cidara Therapeutics, Inc. (CDTX) creators is up 20.68% from the previous month.
- Cidara Therapeutics, Inc. (CDTX) engagements is up 10.64% from the previous week.
- Cidara Therapeutics, Inc. (CDTX) mentions is up 16.82% from the previous month.
- Cidara Therapeutics, Inc. (CDTX) posts created is up 416.67% from the previous week.

### Price: $221.40
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/close.tsv)  
The stock price has surged dramatically, driven by the confirmation of a $9.2 billion acquisition by Merck, alongside a BARDA award, FDA Breakthrough Therapy Designation, and analyst upgrades. Increased social media discussions are amplifying these upward trends.  

24-Hour: 0.03%

1-Year High: $221.40 on 2026-01-06  
1-Year Low: $16.40 on 2025-04-04  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/alt_rank.tsv)  
Cidara Therapeutics, Inc. (CDTX) is currently AltRank #1,803 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] [----]  
[--] Month: [-----] +409  
[--] Months: [-----] +1,160  
[--] Year: [-----] +129  
1-Year High: [-----] on 2026-02-05  
1-Year Low: [--] on 2025-08-16  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +3  
[--] Month: [--] [---]  
1-Year High: [--] on 2025-12-22  
1-Year Low: [--] on 2026-02-01  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [------]  
[--] Week: [------] +11%  
[--] Month: [------] -62%  
[--] Months: [---------] +94%  
[--] Year: [---------] +1,738%  
1-Year High: [---------] on 2025-11-14  
1-Year Low: [--] on 2025-02-23  

Engagements by network (24h):
X: [---]
News: [--]
Reddit: [--]
TikTok: [--]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [---] +11%  
[--] Month: [---] +17%  
[--] Months: [-----] -22%  
[--] Year: [------] +2,534%  
1-Year High: [-----] on 2025-06-24  
1-Year Low: [--] on 2025-04-13  

Mentions by network (24h):
X: [--]
News: [--]
Reddit: [--]
TikTok: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Cidara Therapeutics, Inc. (CDTX) in the last [--] hours which is down 24% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +14%  
[--] Month: [---] +21%  
[--] Months: [-----] -27%  
[--] Year: [-----] +2,295%  
1-Year High: [-----] on 2025-06-23  
1-Year Low: [--] on 2025-04-13  

The most influential creators that mention Cidara Therapeutics, Inc. in the last [--] hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@AlmightyZeezA](/creator/twitter/AlmightyZeezA) | [--]    | [---]       | [--]     | [--]          |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)       | [--]    | [------]    | [--]     | [--]           |

[View More](/list/creators/$cdtx/100)
  
  
### Sentiment: 71%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/sentiment.tsv)  
Current Value: 71%  
Daily Average: 81%  
[--] Week: 100% no change  
[--] Month: 67% -1%  
[--] Months: 67% -31%  
[--] Year: 67% +17%  
1-Year High: 100% on 2025-02-23  
1-Year Low: 33% on 2025-03-13  

Most Supportive Themes:
- Analyst Ratings: (10%) JP Morgan initiated coverage on Cidara Therapeutics with an Overweight rating and a $200 price target.
- BARDA Award: (8%) Cidara Therapeutics received a substantial BARDA award to support manufacturing and clinical development of CD388.
- FDA Breakthrough Therapy Designation: (7%) The FDA granted Breakthrough Therapy Designation to CD388 for the prevention of seasonal influenza.
  
Most Critical Themes:
- Valuation Concerns: (5%) Some analysts express concern about the current valuation of $CDTX, with one noting it seems expensive at a $4.3 billion market cap and that Phase [--] trials could fail.
  
  
  
### Social Dominance: 0.00233%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/social_dominance.tsv)  
Current Value: 0.00233%  
Daily Average: 0.018%  
[--] Week: 0.0025% +0.0015%  
[--] Month: 0.0052% -0.0023%  
[--] Months: 0.0052% -0.0098%  
[--] Year: 0.0052% +0.0022%  
1-Year High: 0.384% on 2025-06-24  
1-Year Low: 0.0002% on 2025-04-13  
  
  
### Market Dominance: 0.00789%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cdtx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$cdtx/time-series/market_dominance.tsv)  
Current Value: 0.00789%  
Daily Average: 0%  
1-Year High: 0.241% on 2025-12-19  
1-Year Low: 0.00779% on 2026-02-02  

### Top Cidara Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"☀ Updated list of TRIPLE & QUADRUPLE digits % gainer MULTI BAGGERS from me in last [--] yr ☀ $LAES - UP 2800+% $LUNRW - UP 1500+% $RKLB - UP 1200% $LITM - UP 1150% $OPTT - UP 1000+% $RR - UP 850% $ATNFW - UP 800% $GNPX - UP 700+% $CDTX - UP 650% $LUNR - UP 600+% $MOB - UP 600% $WKEY - UP 600% $AAOI - UP 550% $SKVI - UP 500% $GRI - UP 450% $HOVR - UP 400% $HOUR - UP 400% $HOVRW - UP 400% $SNOA - UP 375% $GNLX - UP 300+% $RNAZ - UP 300+% $EDBLW - UP 300+% $NUKK - UP 275% $IINN - UP 250% $TSSI - UP 250% $USAR - UP 225% $ALLR - UP 225% $CINGW - UP 225% $PRLD - UP 200+% $BMXI - UP 200+% $SOAR - UP"  
[X Link](https://x.com/SuperDuperInvst/status/1985515074027442596) [@SuperDuperInvst](/creator/x/SuperDuperInvst) 2025-11-04T01:10Z 63.9K followers, 97.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing